TP53 and cancer: Accordingly, we showed that a DNA-damaging agent, doxorubicin, induced senescence in cancer cells and that caffeine, a common inhibitor of PIKKs (ATM, ATR, and DNA-PKc) involved in DDR29, abrogated senescence of both p53+/+ and p53−/− HCT116 cells.